140 related articles for article (PubMed ID: 26899126)
1. Tryptophan Catabolites and Their Impact on Multiple Sclerosis Progression.
Watzlawik JO; Wootla B; Rodriguez M
Curr Pharm Des; 2016; 22(8):1049-59. PubMed ID: 26899126
[TBL] [Abstract][Full Text] [Related]
2. Tryptophan Metabolites and Their Impact on Multiple Sclerosis Progression.
Watzlawik JO; Wootla B; Rodriguez M
Curr Pharm Des; 2015 Dec; ():. PubMed ID: 26667001
[TBL] [Abstract][Full Text] [Related]
3. Understanding the roles of the kynurenine pathway in multiple sclerosis progression.
Lim CK; Brew BJ; Sundaram G; Guillemin GJ
Int J Tryptophan Res; 2010; 3():157-67. PubMed ID: 22084596
[TBL] [Abstract][Full Text] [Related]
4. Current Evidence for a Role of the Kynurenine Pathway of Tryptophan Metabolism in Multiple Sclerosis.
Lovelace MD; Varney B; Sundaram G; Franco NF; Ng ML; Pai S; Lim CK; Guillemin GJ; Brew BJ
Front Immunol; 2016; 7():246. PubMed ID: 27540379
[TBL] [Abstract][Full Text] [Related]
5. Overview of the role of vitamins and minerals on the kynurenine pathway in health and disease.
Majewski M; Kozlowska A; Thoene M; Lepiarczyk E; Grzegorzewski WJ
J Physiol Pharmacol; 2016 Feb; 67(1):3-19. PubMed ID: 27010891
[TBL] [Abstract][Full Text] [Related]
6. The kynurenine pathway and neurodegenerative disease.
Maddison DC; Giorgini F
Semin Cell Dev Biol; 2015 Apr; 40():134-41. PubMed ID: 25773161
[TBL] [Abstract][Full Text] [Related]
7. Recent evidence for an expanded role of the kynurenine pathway of tryptophan metabolism in neurological diseases.
Lovelace MD; Varney B; Sundaram G; Lennon MJ; Lim CK; Jacobs K; Guillemin GJ; Brew BJ
Neuropharmacology; 2017 Jan; 112(Pt B):373-388. PubMed ID: 26995730
[TBL] [Abstract][Full Text] [Related]
8. The serum kynurenine pathway metabolic profile is associated with overweight and obesity in multiple sclerosis.
Kupjetz M; Patt N; Joisten N; Ueland PM; McCann A; Gonzenbach R; Bansi J; Zimmer P
Mult Scler Relat Disord; 2023 Apr; 72():104592. PubMed ID: 36881945
[TBL] [Abstract][Full Text] [Related]
9. Searching for Peripheral Biomarkers in Neurodegenerative Diseases: The Tryptophan-Kynurenine Metabolic Pathway.
Török N; Tanaka M; Vécsei L
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33302404
[TBL] [Abstract][Full Text] [Related]
10. Involvement of quinolinic acid in the neuropathogenesis of amyotrophic lateral sclerosis.
Lee JM; Tan V; Lovejoy D; Braidy N; Rowe DB; Brew BJ; Guillemin GJ
Neuropharmacology; 2017 Jan; 112(Pt B):346-364. PubMed ID: 27265569
[TBL] [Abstract][Full Text] [Related]
11. Quinolinic acid/tryptophan ratios predict neurological disease in SIV-infected macaques and remain elevated in the brain under cART.
Drewes JL; Meulendyke KA; Liao Z; Witwer KW; Gama L; Ubaida-Mohien C; Li M; Notarangelo FM; Tarwater PM; Schwarcz R; Graham DR; Zink MC
J Neurovirol; 2015 Aug; 21(4):449-63. PubMed ID: 25776527
[TBL] [Abstract][Full Text] [Related]
12. The Influence of Kynurenine Metabolites on Neurodegenerative Pathologies.
Pathak S; Nadar R; Kim S; Liu K; Govindarajulu M; Cook P; Watts Alexander CS; Dhanasekaran M; Moore T
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255925
[TBL] [Abstract][Full Text] [Related]
13. The kynurenine pathway in neurodegenerative diseases: mechanistic and therapeutic considerations.
Tan L; Yu JT; Tan L
J Neurol Sci; 2012 Dec; 323(1-2):1-8. PubMed ID: 22939820
[TBL] [Abstract][Full Text] [Related]
14. Kynurenine pathway metabolomics predicts and provides mechanistic insight into multiple sclerosis progression.
Lim CK; Bilgin A; Lovejoy DB; Tan V; Bustamante S; Taylor BV; Bessede A; Brew BJ; Guillemin GJ
Sci Rep; 2017 Feb; 7():41473. PubMed ID: 28155867
[TBL] [Abstract][Full Text] [Related]
15. The Kynurenine Pathway in the Acute and Chronic Phases of Cerebral Ischemia.
Cuartero MI; de la Parra J; García-Culebras A; Ballesteros I; Lizasoain I; Moro MÁ
Curr Pharm Des; 2016; 22(8):1060-73. PubMed ID: 25248805
[TBL] [Abstract][Full Text] [Related]
16. Neurodegeneration in Multiple Sclerosis: Symptoms of Silent Progression, Biomarkers and Neuroprotective Therapy-Kynurenines Are Important Players.
Sandi D; Fricska-Nagy Z; Bencsik K; Vécsei L
Molecules; 2021 Jun; 26(11):. PubMed ID: 34198750
[TBL] [Abstract][Full Text] [Related]
17. The kynurenine pathway in stem cell biology.
Jones SP; Guillemin GJ; Brew BJ
Int J Tryptophan Res; 2013 Sep; 6():57-66. PubMed ID: 24092986
[TBL] [Abstract][Full Text] [Related]
18. L-Tryptophan-kynurenine pathway enzymes are therapeutic target for neuropsychiatric diseases: Focus on cell type differences.
Fujigaki H; Yamamoto Y; Saito K
Neuropharmacology; 2017 Jan; 112(Pt B):264-274. PubMed ID: 26767951
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the kynurenine pathway in NSC-34 cell line: implications for amyotrophic lateral sclerosis.
Chen Y; Brew BJ; Guillemin GJ
J Neurochem; 2011 Sep; 118(5):816-25. PubMed ID: 21182524
[TBL] [Abstract][Full Text] [Related]
20. Involvement of the kynurenine pathway in the pathogenesis of Parkinson's disease.
Lim CK; Fernández-Gomez FJ; Braidy N; Estrada C; Costa C; Costa S; Bessede A; Fernandez-Villalba E; Zinger A; Herrero MT; Guillemin GJ
Prog Neurobiol; 2017 Aug; 155():76-95. PubMed ID: 27072742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
